Javascript must be enabled to continue!
In vitro sumoylation and ubiquitination of annexin I and helicase activity
View through CrossRef
Annexin I, a protein previously termed as lipomodulin or lipocortin I, is a member of the family that bind to phospholipids in a Ca
2+
dependent manner. This protein is a major substrate of the oncogenic tyrosine kinases such as
c‐met
and
c‐src
, thus being proposed to be involved in cell proliferation and differentiation. While annexin I in the nuclei is thought to be involved in cell transformation and/or proliferation, the nuclear translocation of annexin I is facilitated by oxidative stress and possibly by phosphorylation (and Ca
2+
signal). Since annexin I contains the consensus motif, ψKxE, for sumoylation, we tested if annexin I can be sumoylated by Ubc 9
in vitro
. We found that purified bovine annexin I is indeed sumoylated by Ubc 9, and that E3 of the sumoylation system is not required. While nonmodified annexin I has no helicase activity, the sumoylation unmasked a helicase activity. On the other hand, the mono‐ubiquitination of annexin I was found to be catalyzed by Ubc H2a and H2b (hHR 6). This reaction required E3 of the ubiquitination system in the cytosolic fraction of HeLa cells. Difference in properties of their helicase activities will be discussed. These observations suggest that annexin I may play an important role in DNA damage bypass and mutagenesis mediated through modifications with ubiquitin and sumo. (Supported in parts by a grant from the Susan G. Komen Breast Cancer Foundation BCTR0600711)
Title: In vitro sumoylation and ubiquitination of annexin I and helicase activity
Description:
Annexin I, a protein previously termed as lipomodulin or lipocortin I, is a member of the family that bind to phospholipids in a Ca
2+
dependent manner.
This protein is a major substrate of the oncogenic tyrosine kinases such as
c‐met
and
c‐src
, thus being proposed to be involved in cell proliferation and differentiation.
While annexin I in the nuclei is thought to be involved in cell transformation and/or proliferation, the nuclear translocation of annexin I is facilitated by oxidative stress and possibly by phosphorylation (and Ca
2+
signal).
Since annexin I contains the consensus motif, ψKxE, for sumoylation, we tested if annexin I can be sumoylated by Ubc 9
in vitro
.
We found that purified bovine annexin I is indeed sumoylated by Ubc 9, and that E3 of the sumoylation system is not required.
While nonmodified annexin I has no helicase activity, the sumoylation unmasked a helicase activity.
On the other hand, the mono‐ubiquitination of annexin I was found to be catalyzed by Ubc H2a and H2b (hHR 6).
This reaction required E3 of the ubiquitination system in the cytosolic fraction of HeLa cells.
Difference in properties of their helicase activities will be discussed.
These observations suggest that annexin I may play an important role in DNA damage bypass and mutagenesis mediated through modifications with ubiquitin and sumo.
(Supported in parts by a grant from the Susan G.
Komen Breast Cancer Foundation BCTR0600711).
Related Results
Activation of Endothelial Cells by β2-Glycoprotein I (β2GPI) Antibodies Is Mediated by Annexin II Cross Linking and May Involve TLR4.
Activation of Endothelial Cells by β2-Glycoprotein I (β2GPI) Antibodies Is Mediated by Annexin II Cross Linking and May Involve TLR4.
Abstract
The antiphospholipid antibody syndrome (APS) is characterized by the presence of circulating antiphospholipid antibodies (APLA) in association with thrombos...
Annexin A1 conveys neuroprotective function via inhibiting oxidative stress in diffuse axonal injury of rats
Annexin A1 conveys neuroprotective function via inhibiting oxidative stress in diffuse axonal injury of rats
Abstract
Purpose
Diffuse axonal injury (DAI) is a critical pathological facet of traumatic brain injury (TBI). Oxidative stress plays a significant role in progress of DAI...
TRIM28 Facilitates Chronic Myeloid Leukemia Progression By Enhancing Sumoylation and Stability of BCR-ABL
TRIM28 Facilitates Chronic Myeloid Leukemia Progression By Enhancing Sumoylation and Stability of BCR-ABL
Chronic myeloid leukemia (CML) is a hematopoietic malignancy caused by the BCR-ABL fusion gene. Although tyrosine kinase inhibitors (TKIs) targeting the oncoprotein BCR-ABL have dr...
Mapping of helicase and helicase substrate-binding domains on simian virus 40 large T antigen
Mapping of helicase and helicase substrate-binding domains on simian virus 40 large T antigen
We generated fragments of simian virus 40 large tumor antigen (T antigen) by tryptic digestion and assayed them for helicase activity and helicase substrate (mostly single-stranded...
Abstract 209: Identification of β-catenin lysine 394 as a novel charge button and ubiquitination site by Rad6B
Abstract 209: Identification of β-catenin lysine 394 as a novel charge button and ubiquitination site by Rad6B
Abstract
Clinical evidence suggests that β-catenin accumulation in breast cancer is associated with poor prognosis. Accumulation of β-catenin occurs even though acti...
Non-SUMOylated alternative spliced isoforms of alpha-synuclein are more aggregation-prone and toxic
Non-SUMOylated alternative spliced isoforms of alpha-synuclein are more aggregation-prone and toxic
Abstract
Background:
To date, four alternative splicing isoforms arising from exon skipping have been identified for α-Synuclein (α-Syn), the main constituent of the abnor...
Expression Level of Annexin A1 Contributes to the Evaluation of the Disease Progression and Treatment Effect of Lung Adenocarcinoma: A New Perspective from Retrospective Analysis
Expression Level of Annexin A1 Contributes to the Evaluation of the Disease Progression and Treatment Effect of Lung Adenocarcinoma: A New Perspective from Retrospective Analysis
Abstract
Background: Increased Annexin A1 has been showed to be related to malignant biological characteristics of tumors; the aim of this study was to evaluate the relatio...
SUMOylation Regulates Transcription by the Progesterone Receptor A Isoform in a Target Gene Selective Manner
SUMOylation Regulates Transcription by the Progesterone Receptor A Isoform in a Target Gene Selective Manner
Luminal breast cancers express estrogen (ER) and progesterone (PR) receptors, and respond to endocrine therapies. However, some ER+PR+ tumors display intrinsic or acquired resistan...

